Александрова И. В., Рей С. И., Хватов В. Б., Боровкова Н. В., Ильинский М. Е., Абакумов М. М.

ЛИТЕРАТУРА
1. Alberti C., Brun-Buisson C., Burchardi H., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study // Intensive Care Med. — 2002. — V. 28. — N 2. — P. 108—121.
2. Angus D. C., Linde-Zwirble W. T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care // Crit. Care Med. — 2001. — V. 29. — N 7. — P. 1303—1310.
3. Bellomo R., Honore P. M., Matson J., et al. Extracorporeal blood treatment (EBT) methods in SIRS/Sepsis // Int. J. Artif. Organs. — 2005. — V. 28. — N 5. — P. 450—458.
4. Bengsch S., Boos K. S., Nagel D., et al. Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study // Shock. — 2005. — V. 23. — N 6. — P. 494—500.
5. Bommhardt U., Chang K. C., Swanson P. E., et al. Akt Decreases Lymphocyte Apoptosis and Improves Survival in Sepsis // J. Immunol. — 2004. — V. 172. — N 12. — P. 7583—7591.
6. Bone R. C., Sibbald W. J., Sprung C. L. The ACCP-SCCM consensus conference on sepsis and organ failure // Chest. — 1992. — Vol. 101. — N 6. — P. 1481—1483.
7. Busund R., Koukline V., Utrobin U., Nedashkovsky E. Plasmapheresis in severe sepsis and septic shock: a prospective, randomised, controlled trial // Intensive Care Med. — 2002. — Vol. 28. — N 10. — P. 1434—1439.
8. Engel C., Brunkhorst F. M., Bone H. G., et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study // Intensive Care Med. — 2007. — V. 33. — N 4. — P. 606—618.
9. Fialkow L., Fochesatto Filho L., Bozzetti M. C., et al. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome // Crit. Care. 2006. — V. 10. — N 6. — P. 155.
10. Giamarellos-Bourboulis E. J., Routsi C., Plachouras D., et al. Early apoptosis of blood monocytes in the septic host: is it a mechanism of protection in the event of septic shock? // Crit. Care. — 2006. — V. 10. — N 3. — R. 76.
11. Hirano T., Hirasawa H., Oda S., et al. Modulation of polymorphonuclear leukocyte apoptosis in the critically ill by removal of cytokines with continuous hemodiafiltration // Blood Purif. — 2004. — V. 22. — N 2. — P. 188—197.
12. Hirasawa H., Oda S., Matsuda K. Continuous hemodiafiltration with cytokineadsorbing hemofilter in the treatment of severe sepsis and septic shock // Contrib Nephrol. — 2007. — V. 156. — P. 365—370.
13. Hoesel L. M., Gao H., Ward P. A. New insights into cellular mechanisms during sepsis // Immunol. Res. — 2006. — V. 34. — N 2. — P. 133—141.
14. House A. A., Ronco C. Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury // Blood Purif. — 2008. — V. 26. — N 1. — P. 30—35.
15. Kellum J. A., Johnson J. P., Kramer D., et al. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome // Crit. Care Med. — 1998. — Vol. 26. — N 12. — P. 1995—2000.
16. Knaus W. A., Draper E. A., Wagner D. P., Zimmerman J. E. APACHE II: a severity of disease classification system // Crit. Care Med. — 1985. — Vol. 13. — N 10. — P. 818—829.
17. Kojika M., Sato N., Yaegashi Y., et al. Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity // Ther. Apher. Dial. — 2006. — V. 10. — N 1. — P. 12—18.
18. Le Gall J. R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study // JAMA. — 1993. — Vol. 270. — N 24. — P. 2957—2963.
19. Linenberger M. L., Price T. H. Use of cellular and plasma apheresis in the critically ill patient // J. Intensive Care Med. — 2005. — Vol. 20. — N 2. — P. 18—27.
20. Lush C. W., Kvietys P. R. Microvascular dysfunction in sepsis // Microcirculation. — 2000. — V. 7. — N 2. — P. 83—101.
21. Mahidhara R., Billiar T. R. Apoptosis in sepsis // Crit. Care Med. — 2000. — V. 28. — Suppl. N 4. — P. 105—113.
22. Martin G. S., Mannino D. M., Eaton S., Moss M. The epidemiology of sepsis in the United States from 1979 through 2000 // N. Engl. J. Med. — 2003. — V. 348. — N 16. — P. 1546—1554.
23. Power C., Fanning N., Redmond H. P. Cellular apoptosis and organ injury in sepsis: a review // Shock. — 2002. — V. 18. — N 3. — P. 197—211.
24. Reeves J. H., Butt W. W., Shann F., et al. Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group // Crit. Care Med. — 1999. — V. 27. — N 10. — P. 2096—2104.
25. Riedemann N. C., Guo R. F., Ward P. A. Novel Strategies for the Treatment of Sepsis // Nat. Med. — 2003. — Vol. 9. — N 5 — P. 517—524.
26. Smith J. W., Gamelli R. L., Jones S. B., Shankar R. Immunologic responses to critical injury and sepsis // J. Intensive Care Med. — 2006. — V. 21. — N 3. — P. 160—172.
27. Stegmayr B. G. Is there a future for adsorption techniques in sepsis // Blood Purif. — 2000. — Vol. 18. — N 2. — P. 149—155.
28. Venkataraman R., Subramanian S., Kellum J. A. Clinical review: Extracorporeal blood purification in severe sepsis // Crit. Care. — 2003. — Vol. 7. — N 2. — P. 139—145.
29. Vincent J. L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine // Intensive Care Med. — 1996. — Vol. 22. — N 7. — P. 707—710.